Literature DB >> 26687903

The first patient treatment of computed tomography ventilation functional image-guided radiotherapy for lung cancer.

Tokihiro Yamamoto1, Sven Kabus2, Matthieu Bal3, Paul Keall4, Stanley Benedict5, Megan Daly5.   

Abstract

BACKGROUND AND
PURPOSE: Radiotherapy that selectively avoids irradiating highly-functional lung regions may reduce pulmonary toxicity. We report on the first clinical implementation and patient treatment of lung functional image-guided radiotherapy using an emerging technology, computed tomography (CT) ventilation imaging.
MATERIAL AND METHODS: A protocol was developed to investigate the safety and feasibility of CT ventilation functional image-guided radiotherapy. CT ventilation imaging is based on (1) deformable image registration of four-dimensional (4D) CT images, and (2) quantitative image analysis for regional volume change, a surrogate for ventilation. CT ventilation functional image-guided radiotherapy plans were designed to minimize specific lung dose-function metrics, including functional V20 (fV20), while maintaining target coverage and meeting standard constraints to other critical organs.
RESULTS: CT ventilation functional image-guided treatment planning reduced the lung fV20 by 5% compared to an anatomic image-guided plan for an enrolled patient with stage IIIB non-small cell lung cancer. Although the doses to several other critical organs increased, the necessary constraints were all met.
CONCLUSIONS: An emerging technology, CT ventilation imaging has been translated into the clinic and used in functional image-guided radiotherapy for the first time. This milestone represents an important first step toward hypothetically reduced pulmonary toxicity in lung cancer radiotherapy.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  4D CT; Deformable image registration; Lung cancer; Lung functional imaging; Radiation pneumonitis

Mesh:

Year:  2015        PMID: 26687903     DOI: 10.1016/j.radonc.2015.11.006

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  26 in total

1.  The VAMPIRE challenge: A multi-institutional validation study of CT ventilation imaging.

Authors:  John Kipritidis; Bilal A Tahir; Guillaume Cazoulat; Michael S Hofman; Shankar Siva; Jason Callahan; Nicholas Hardcastle; Tokihiro Yamamoto; Gary E Christensen; Joseph M Reinhardt; Noriyuki Kadoya; Taylor J Patton; Sarah E Gerard; Isabella Duarte; Ben Archibald-Heeren; Mikel Byrne; Rick Sims; Scott Ramsay; Jeremy T Booth; Enid Eslick; Fiona Hegi-Johnson; Henry C Woodruff; Rob H Ireland; Jim M Wild; Jing Cai; John E Bayouth; Kristy Brock; Paul J Keall
Journal:  Med Phys       Date:  2019-02-01       Impact factor: 4.071

2.  Evaluating the Toxicity Reduction With Computed Tomographic Ventilation Functional Avoidance Radiation Therapy.

Authors:  Austin M Faught; Yuya Miyasaka; Noriyuki Kadoya; Richard Castillo; Edward Castillo; Yevgeniy Vinogradskiy; Tokihiro Yamamoto
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-04-26       Impact factor: 7.038

3.  Evaluating Which Dose-Function Metrics Are Most Critical for Functional-Guided Radiation Therapy.

Authors:  Austin M Faught; Tokihiro Yamamoto; Richard Castillo; Edward Castillo; Jingjing Zhang; Moyed Miften; Yevgeniy Vinogradskiy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-04-08       Impact factor: 7.038

4.  Functional lung avoidance and response-adaptive escalation (FLARE) RT: Multimodality plan dosimetry of a precision radiation oncology strategy.

Authors:  Eunsin Lee; Jing Zeng; Robert S Miyaoka; Jatinder Saini; Paul E Kinahan; George A Sandison; Tony Wong; Hubert J Vesselle; Ramesh Rengan; Stephen R Bowen
Journal:  Med Phys       Date:  2017-06-01       Impact factor: 4.071

5.  Interim Analysis of a Two-Institution, Prospective Clinical Trial of 4DCT-Ventilation-based Functional Avoidance Radiation Therapy.

Authors:  Yevgeniy Vinogradskiy; Chad G Rusthoven; Leah Schubert; Bernard Jones; Austin Faught; Richard Castillo; Edward Castillo; Laurie E Gaspar; Jennifer Kwak; Timothy Waxweiler; Michele Dougherty; Dexiang Gao; Craig Stevens; Moyed Miften; Brian Kavanagh; Thomas Guerrero; Inga Grills
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-10-18       Impact factor: 7.038

6.  Efficacy evaluation of 2D, 3D U-Net semantic segmentation and atlas-based segmentation of normal lungs excluding the trachea and main bronchi.

Authors:  Takafumi Nemoto; Natsumi Futakami; Masamichi Yagi; Atsuhiro Kumabe; Atsuya Takeda; Etsuo Kunieda; Naoyuki Shigematsu
Journal:  J Radiat Res       Date:  2020-03-23       Impact factor: 2.724

7.  Stereotactic Body Radiotherapy Based on 99mTc-GSA SPECT Image-guided Inverse Planning for Hepatocellular Carcinoma.

Authors:  Yudai Kai; Ryo Toya; Tetsuo Saito; Tomohiko Matsuyama; Yoshiyuki Fukugawa; Shinya Shiraishi; Yoshinobu Shimohigashi; Natsuo Oya
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

8.  N-Phase Local Expansion Ratio for Characterizing Out-of-Phase Lung Ventilation.

Authors:  Wei Shao; Taylor J Patton; Sarah E Gerard; Yue Pan; Joseph M Reinhardt; Oguz C Durumeric; John E Bayouth; Gary E Christensen
Journal:  IEEE Trans Med Imaging       Date:  2019-12-30       Impact factor: 10.048

9.  Modeling Patient-Specific Dose-Function Response for Enhanced Characterization of Personalized Functional Damage.

Authors:  Daniel Rocky Owen; Phillip S Boonstra; Benjamin L Viglianti; James M Balter; Matthew J Schipper; William C Jackson; Issam El Naqa; Shruti Jolly; Randall K Ten Haken; Feng-Ming Spring Kong; Martha M Matuszak
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-06-01       Impact factor: 7.038

10.  Comparison of regional lung perfusion response on longitudinal MAA SPECT/CT in lung cancer patients treated with and without functional tissue-avoidance radiation therapy.

Authors:  Hannah Mary T Thomas; Jing Zeng; Howard J Lee; Balu Krishna Sasidharan; Paul E Kinahan; Robert S Miyaoka; Hubert J Vesselle; Ramesh Rengan; Stephen R Bowen
Journal:  Br J Radiol       Date:  2019-08-12       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.